世界の線維筋痛症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Fibromyalgia Treatment Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2363 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、線維筋痛症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・線維筋痛症治療薬の市場動向 ・企業の競争状況、市場シェア ・線維筋痛症治療薬の種類別市場規模（シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他） ・線維筋痛症治療薬の用途別市場規模（病院、クリニック、その他） ・線維筋痛症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・線維筋痛症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・線維筋痛症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・線維筋痛症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・線維筋痛症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eli Lilly、Actavis Generics、Merck Sharp and Dohme、Daiichi Sankyo、Innovative Med Concepts、Meda、Meiji Seika、Switch Biotech、Theravance、Zynerba Pharmaceuticals、Tonix Pharmaceuticals Holding Corp. (TNXP)、Daiichi Sankyo、Forest Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Pierre Fabre Medicament） ・結論

Market Analysis and Insights: Global Fibromyalgia Treatment Drug Market
The global Fibromyalgia Treatment Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fibromyalgia Treatment Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fibromyalgia Treatment Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fibromyalgia Treatment Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fibromyalgia Treatment Drug market.

Global Fibromyalgia Treatment Drug Scope and Market Size
Fibromyalgia Treatment Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibromyalgia Treatment Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cymbalta (Duloxetine)
Savella (Milnacipran)
Lyrica (Pregabalin)
Pancuronium
Others

Segment by Application
Hospital
Clinic
Household
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Eli Lilly
Actavis Generics
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Market by Application
1.3.1 Global Fibromyalgia Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Fibromyalgia Treatment Drug Market Perspective (2016-2027)
2.2 Fibromyalgia Treatment Drug Growth Trends by Regions
2.2.1 Fibromyalgia Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fibromyalgia Treatment Drug Historic Market Share by Regions (2016-2021)
2.2.3 Fibromyalgia Treatment Drug Forecasted Market Size by Regions (2022-2027)
2.3 Fibromyalgia Treatment Drug Industry Dynamic
2.3.1 Fibromyalgia Treatment Drug Market Trends
2.3.2 Fibromyalgia Treatment Drug Market Drivers
2.3.3 Fibromyalgia Treatment Drug Market Challenges
2.3.4 Fibromyalgia Treatment Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Fibromyalgia Treatment Drug Players by Revenue
3.1.1 Global Top Fibromyalgia Treatment Drug Players by Revenue (2016-2021)
3.1.2 Global Fibromyalgia Treatment Drug Revenue Market Share by Players (2016-2021)
3.2 Global Fibromyalgia Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fibromyalgia Treatment Drug Revenue
3.4 Global Fibromyalgia Treatment Drug Market Concentration Ratio
3.4.1 Global Fibromyalgia Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Treatment Drug Revenue in 2020
3.5 Fibromyalgia Treatment Drug Key Players Head office and Area Served
3.6 Key Players Fibromyalgia Treatment Drug Product Solution and Service
3.7 Date of Enter into Fibromyalgia Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Treatment Drug Breakdown Data by Type
4.1 Global Fibromyalgia Treatment Drug Historic Market Size by Type (2016-2021)
4.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2022-2027)

5 Fibromyalgia Treatment Drug Breakdown Data by Application
5.1 Global Fibromyalgia Treatment Drug Historic Market Size by Application (2016-2021)
5.2 Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Fibromyalgia Treatment Drug Market Size (2016-2027)
6.2 North America Fibromyalgia Treatment Drug Market Size by Type
6.2.1 North America Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
6.2.2 North America Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
6.2.3 North America Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
6.3 North America Fibromyalgia Treatment Drug Market Size by Application
6.3.1 North America Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
6.3.2 North America Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
6.3.3 North America Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
6.4 North America Fibromyalgia Treatment Drug Market Size by Country
6.4.1 North America Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
6.4.2 North America Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Fibromyalgia Treatment Drug Market Size (2016-2027)
7.2 Europe Fibromyalgia Treatment Drug Market Size by Type
7.2.1 Europe Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
7.2.2 Europe Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
7.2.3 Europe Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
7.3 Europe Fibromyalgia Treatment Drug Market Size by Application
7.3.1 Europe Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
7.3.2 Europe Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
7.3.3 Europe Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
7.4 Europe Fibromyalgia Treatment Drug Market Size by Country
7.4.1 Europe Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
7.4.2 Europe Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size (2016-2027)
8.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type
8.2.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application
8.3.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region
8.4.1 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Fibromyalgia Treatment Drug Market Size (2016-2027)
9.2 Latin America Fibromyalgia Treatment Drug Market Size by Type
9.2.1 Latin America Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
9.2.2 Latin America Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
9.2.3 Latin America Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
9.3 Latin America Fibromyalgia Treatment Drug Market Size by Application
9.3.1 Latin America Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
9.3.2 Latin America Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
9.3.3 Latin America Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
9.4 Latin America Fibromyalgia Treatment Drug Market Size by Country
9.4.1 Latin America Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
9.4.2 Latin America Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size (2016-2027)
10.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type
10.2.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application
10.3.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country
10.4.1 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fibromyalgia Treatment Drug Introduction
11.1.4 Pfizer Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Fibromyalgia Treatment Drug Introduction
11.2.4 Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Actavis Generics
11.3.1 Actavis Generics Company Details
11.3.2 Actavis Generics Business Overview
11.3.3 Actavis Generics Fibromyalgia Treatment Drug Introduction
11.3.4 Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.3.5 Actavis Generics Recent Development
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Details
11.4.2 Merck Sharp and Dohme Business Overview
11.4.3 Merck Sharp and Dohme Fibromyalgia Treatment Drug Introduction
11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.4.5 Merck Sharp and Dohme Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction
11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.5.5 Daiichi Sankyo Recent Development
11.6 Innovative Med Concepts
11.6.1 Innovative Med Concepts Company Details
11.6.2 Innovative Med Concepts Business Overview
11.6.3 Innovative Med Concepts Fibromyalgia Treatment Drug Introduction
11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.6.5 Innovative Med Concepts Recent Development
11.7 Meda
11.7.1 Meda Company Details
11.7.2 Meda Business Overview
11.7.3 Meda Fibromyalgia Treatment Drug Introduction
11.7.4 Meda Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.7.5 Meda Recent Development
11.8 Meiji Seika
11.8.1 Meiji Seika Company Details
11.8.2 Meiji Seika Business Overview
11.8.3 Meiji Seika Fibromyalgia Treatment Drug Introduction
11.8.4 Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.8.5 Meiji Seika Recent Development
11.9 Switch Biotech
11.9.1 Switch Biotech Company Details
11.9.2 Switch Biotech Business Overview
11.9.3 Switch Biotech Fibromyalgia Treatment Drug Introduction
11.9.4 Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.9.5 Switch Biotech Recent Development
11.10 Theravance
11.10.1 Theravance Company Details
11.10.2 Theravance Business Overview
11.10.3 Theravance Fibromyalgia Treatment Drug Introduction
11.10.4 Theravance Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.10.5 Theravance Recent Development
11.11 Zynerba Pharmaceuticals
11.11.1 Zynerba Pharmaceuticals Company Details
11.11.2 Zynerba Pharmaceuticals Business Overview
11.11.3 Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Introduction
11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.11.5 Zynerba Pharmaceuticals Recent Development
11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Introduction
11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Fibromyalgia Treatment Drug Introduction
11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.13.5 Daiichi Sankyo Recent Development
11.14 Forest Pharmaceuticals, Inc.
11.14.1 Forest Pharmaceuticals, Inc. Company Details
11.14.2 Forest Pharmaceuticals, Inc. Business Overview
11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Introduction
11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.14.5 Forest Pharmaceuticals, Inc. Recent Development
11.15 Boehringer Ingelheim GmbH
11.15.1 Boehringer Ingelheim GmbH Company Details
11.15.2 Boehringer Ingelheim GmbH Business Overview
11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Introduction
11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.15.5 Boehringer Ingelheim GmbH Recent Development
11.16 Pierre Fabre Medicament
11.16.1 Pierre Fabre Medicament Company Details
11.16.2 Pierre Fabre Medicament Business Overview
11.16.3 Pierre Fabre Medicament Fibromyalgia Treatment Drug Introduction
11.16.4 Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2016-2021)
11.16.5 Pierre Fabre Medicament Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cymbalta (Duloxetine)
Table 3. Key Players of Savella (Milnacipran)
Table 4. Key Players of Lyrica (Pregabalin)
Table 5. Key Players of Pancuronium
Table 6. Key Players of Others
Table 7. Global Fibromyalgia Treatment Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Fibromyalgia Treatment Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Fibromyalgia Treatment Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Fibromyalgia Treatment Drug Market Share by Regions (2016-2021)
Table 11. Global Fibromyalgia Treatment Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Fibromyalgia Treatment Drug Market Share by Regions (2022-2027)
Table 13. Fibromyalgia Treatment Drug Market Trends
Table 14. Fibromyalgia Treatment Drug Market Drivers
Table 15. Fibromyalgia Treatment Drug Market Challenges
Table 16. Fibromyalgia Treatment Drug Market Restraints
Table 17. Global Fibromyalgia Treatment Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Fibromyalgia Treatment Drug Market Share by Players (2016-2021)
Table 19. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment Drug as of 2020)
Table 20. Ranking of Global Top Fibromyalgia Treatment Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Fibromyalgia Treatment Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Fibromyalgia Treatment Drug Product Solution and Service
Table 24. Date of Enter into Fibromyalgia Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Fibromyalgia Treatment Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Fibromyalgia Treatment Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Fibromyalgia Treatment Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Fibromyalgia Treatment Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Fibromyalgia Treatment Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Fibromyalgia Treatment Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Fibromyalgia Treatment Drug Product
Table 67. Pfizer Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Fibromyalgia Treatment Drug Product
Table 72. Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly Recent Development
Table 74. Actavis Generics Company Details
Table 75. Actavis Generics Business Overview
Table 76. Actavis Generics Fibromyalgia Treatment Drug Product
Table 77. Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 78. Actavis Generics Recent Development
Table 79. Merck Sharp and Dohme Company Details
Table 80. Merck Sharp and Dohme Business Overview
Table 81. Merck Sharp and Dohme Fibromyalgia Treatment Drug Product
Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 83. Merck Sharp and Dohme Recent Development
Table 84. Daiichi Sankyo Company Details
Table 85. Daiichi Sankyo Business Overview
Table 86. Daiichi Sankyo Fibromyalgia Treatment Drug Product
Table 87. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 88. Daiichi Sankyo Recent Development
Table 89. Innovative Med Concepts Company Details
Table 90. Innovative Med Concepts Business Overview
Table 91. Innovative Med Concepts Fibromyalgia Treatment Drug Product
Table 92. Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 93. Innovative Med Concepts Recent Development
Table 94. Meda Company Details
Table 95. Meda Business Overview
Table 96. Meda Fibromyalgia Treatment Drug Product
Table 97. Meda Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 98. Meda Recent Development
Table 99. Meiji Seika Company Details
Table 100. Meiji Seika Business Overview
Table 101. Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 102. Meiji Seika Recent Development
Table 103. Switch Biotech Company Details
Table 104. Switch Biotech Business Overview
Table 105. Switch Biotech Fibromyalgia Treatment Drug Product
Table 106. Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 107. Switch Biotech Recent Development
Table 108. Theravance Company Details
Table 109. Theravance Business Overview
Table 110. Theravance Fibromyalgia Treatment Drug Product
Table 111. Theravance Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 112. Theravance Recent Development
Table 113. Zynerba Pharmaceuticals Company Details
Table 114. Zynerba Pharmaceuticals Business Overview
Table 115. Zynerba Pharmaceuticals Fibromyalgia Treatment Drug Product
Table 116. Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 117. Zynerba Pharmaceuticals Recent Development
Table 118. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Treatment Drug Product
Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
Table 123. Daiichi Sankyo Company Details
Table 124. Daiichi Sankyo Business Overview
Table 125. Daiichi Sankyo Fibromyalgia Treatment Drug Product
Table 126. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 127. Daiichi Sankyo Recent Development
Table 128. Forest Pharmaceuticals, Inc. Company Details
Table 129. Forest Pharmaceuticals, Inc. Business Overview
Table 130. Forest Pharmaceuticals, Inc. Fibromyalgia Treatment Drug Product
Table 131. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 132. Forest Pharmaceuticals, Inc. Recent Development
Table 133. Boehringer Ingelheim GmbH Company Details
Table 134. Boehringer Ingelheim GmbH Business Overview
Table 135. Boehringer Ingelheim GmbH Fibromyalgia Treatment Drug Product
Table 136. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 137. Boehringer Ingelheim GmbH Recent Development
Table 138. Pierre Fabre Medicament Company Details
Table 139. Pierre Fabre Medicament Business Overview
Table 140. Pierre Fabre Medicament Fibromyalgia Treatment Drug Product
Table 141. Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2016-2021) & (US$ Million)
Table 142. Pierre Fabre Medicament Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibromyalgia Treatment Drug Market Share by Type: 2020 VS 2027
Figure 2. Cymbalta (Duloxetine) Features
Figure 3. Savella (Milnacipran) Features
Figure 4. Lyrica (Pregabalin) Features
Figure 5. Pancuronium Features
Figure 6. Others Features
Figure 7. Global Fibromyalgia Treatment Drug Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Household Case Studies
Figure 11. Others Case Studies
Figure 12. Fibromyalgia Treatment Drug Report Years Considered
Figure 13. Global Fibromyalgia Treatment Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Fibromyalgia Treatment Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Fibromyalgia Treatment Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Fibromyalgia Treatment Drug Market Share by Regions (2022-2027)
Figure 17. Global Fibromyalgia Treatment Drug Market Share by Players in 2020
Figure 18. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Drug Revenue in 2020
Figure 20. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
Figure 24. North America Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
Figure 25. North America Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
Figure 26. United States Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
Figure 30. Europe Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
Figure 31. Europe Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
Figure 32. Germany Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Fibromyalgia Treatment Drug Market Share by Region (2016-2027)
Figure 42. China Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
Figure 50. Latin America Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
Figure 51. Latin America Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
Figure 52. Mexico Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Fibromyalgia Treatment Drug Market Share by Country (2016-2027)
Figure 58. Turkey Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Fibromyalgia Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 63. Actavis Generics Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 64. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 65. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 66. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 67. Meda Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 68. Meiji Seika Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 69. Switch Biotech Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 70. Theravance Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 71. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 72. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 73. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 74. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 75. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 76. Pierre Fabre Medicament Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---